Immunopathogenesis of COVID-19 and early immunomodulators
The novel coronavirus disease 2019 (COVID-19) is spreading globally. Although its etiologic agent is discovered as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), there are many unsolved issues in COVID-19 and other infectious diseases. The causes of different clinical phenotypes and i...
Main Authors: | Kyung-Yil Lee, Jung-Woo Rhim, Jin-Han Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Pediatric Society
2020-07-01
|
Series: | Clinical and Experimental Pediatrics |
Subjects: | |
Online Access: | http://www.e-cep.org/upload/pdf/cep-2020-00759.pdf |
Similar Items
-
Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy
by: Kyung-Yil Lee
Published: (2017-02-01) -
Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
by: Fehmi Hindilerden, et al.
Published: (2020-07-01) -
Severe immune thrombocytopenia in a critically ill COVID-19 patient
by: Ziga Martincic, et al.
Published: (2020-10-01) -
Treatment of a case of COVID-19 by intravenous immunoglobulin
by: Mustafa Çolak, et al.
Published: (2021-03-01) -
Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
by: Yining Li, et al.
Published: (2019-08-01)